about
Incidence of acute otitis media in children below 6 years of age seen in medical practices in five East European countries.The role of the soluble urokinase plasminogen activator (suPAR) in children with pneumonia.A randomized study of fever prophylaxis and the immunogenicity of routine pediatric vaccinations.Cost Burden of Severe Community-Acquired Rotavirus Gastroenteritis Requiring Hospitalization in the Czech Republic, Slovakia, Poland, and Hungary: A Retrospective Patient Chart Review.Congenital hypothyroidism - Polish recommendations for therapy, treatment monitoring, and screening tests in special categories of neonates with increased risk of hypothyroidism.Soluble urokinase plasminogen activator receptor: an indicator of pneumonia severity in children.Gastrointestinal disorders next to respiratory infections as leading symptoms of X-linked agammaglobulinemia in children - 34-year experience of a single center.Polish consensus guidelines on the use of acyclovir in the treatment and prevention of VZV and HSV infections.A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trial.Sodium and copeptin levels in children with community acquired pneumonia.Active immunization of children with leukemias and lymphomas against infection by hepatitis B virus.Diminished presentation of complement regulatory protein CD55 on red blood cells from patients with hereditary haemolytic anaemias.Diversity of thalassemia variants in Poland - screening by real-time PCR.Vitamin D Supplementation Guidelines for General Population and Groups at Risk of Vitamin D Deficiency in Poland-Recommendations of the Polish Society of Pediatric Endocrinology and Diabetes and the Expert Panel With Participation of National SpeciaRelapses after termination of therapy of acute lymphoblastic leukemia in childrenKinetics of humoral response in children with acute lymphoblastic leukemia immunized with influenza vaccine in 1993 in PolandImmunogenicity of subunit trivalent influenza vaccine in children with acute lymphoblastic leukemia[Screening in specific categories of neonates exposed to congenital hypothyroidism][The treatment and monitoring of the therapy of congenital hypothyroidism]Influenza: Underestimated in Children Below 2 Years of AgeImmunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study
P50
Q36085527-F1B15EDE-723C-49C8-9E43-68AA2B00EAAFQ38324895-1B11BFD1-1FEC-4368-B048-B37AE02D0975Q38379945-3AAF04ED-4DA1-46B5-8488-96025941FC82Q39018357-C7AD6FB7-36BA-4AD8-AD2A-3ED392F2494DQ39201653-E4A8C452-E87C-4846-AE25-BCD5A3FE8CB1Q40186989-8A9AFAE7-AC7A-4447-BD11-A86E3458E5C7Q40307695-D7D57735-34DB-4A83-BC3A-87CEC61ECAE1Q40880185-8B09E7DD-BEDA-4801-BFCB-F5F36CC8BBD0Q41400370-74F74871-55C6-4A7B-A3C0-37A2CF3DE73FQ41727427-2E698544-22DA-4CD4-A551-721267E10C17Q45777357-B82A8800-588A-4D2A-95F5-C98B369275D1Q47722339-9760CDC2-1581-4C13-8F23-E3EF15478F59Q54505505-41A7DE11-38E7-451E-8E57-E06F82D70123Q55283720-2AA8596F-3221-4B04-8FB0-CFB19820784AQ72646321-9B29FF15-5DA9-4AF7-8421-FB8101685DE9Q73571985-704DE4D4-E59B-4D3A-A1A9-75F548811901Q74287647-E3BCFB2A-E6EB-4D43-8467-4982038C3620Q87614737-A3E4BB7B-4DDD-49BE-84EC-0E7594DF6A62Q87614739-6AD721C9-C164-43B8-81DC-E3CAC8454B98Q89563755-9FE990BC-4BA1-42D4-B6F8-2D5C9E89EA00Q90578103-4B21ED7B-528B-48FE-AFDD-54501637003A
P50
description
researcher
@en
wetenschapper
@nl
name
T Jackowska
@en
T Jackowska
@nl
type
label
T Jackowska
@en
T Jackowska
@nl
prefLabel
T Jackowska
@en
T Jackowska
@nl
P106
P31
P496
0000-0003-0131-7854